The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday, Nov. 26, announced proposed changes in Medicare and Medicaid that would formally recognize obesity as a disease, meaning ...
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
Access to the medication is limited, especially since medications like Wegovy and Zepbound are not covered by most government ...
On Tuesday night, Trump nominated Dr. Jay Bhattacharya to lead the National Institutes of Health, tapping an opponent of ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
13h
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback